Summary of HRES 396 — Tardive Dyskinesia Awareness Week

Overview

HRES 396 is a House Resolution that expresses support for designating a specific week in May 2025 as “Tardive Dyskinesia Awareness Week.” The designation covered in the measure is the week of May 4, 2025, through May 10, 2025. The resolution urges the American public to become better informed about tardive dyskinesia.

Purpose and Intent

• Signifies congressional support for raising public awareness about tardive dyskinesia (TD), a movement disorder often associated with prolonged use of certain antipsychotic medications.
• Encourages individuals across the United States to increase their understanding of TD and its effects.

Key Provisions

• Expresses support for designating a formal community awareness week focused on tardive dyskinesia.
• Encourages widespread public education and awareness about tardive dyskinesia among U.S. residents.

Note: As a resolution, the bill does not establish new laws, create regulatory requirements, or authorize funding. Its primary function is ceremonial and educational, signaling bipartisan support for TD awareness.

Legislative Status and Timeline

• Introduced in the House: May 7, 2025.
• Referred to: House Committee on Energy and Commerce (same day as introduction).
• Status: Submitted in the House as of the latest action provided.

Sponsors

• Primary sponsor: Scott H. Peters.
• Cosponsors: Aaron Bean, Kevin Mullin, Gus M. Bilirakis.

Who Is Affected

• The designation primarily affects awareness initiatives and public health education efforts. It does not impose new duties on individuals or organizations, but it may encourage hospitals, clinics, patient groups, and educational institutions to host events or share information during the designated TD Awareness Week.

Potential Impact

• Increased public knowledge about tardive dyskinesia, its symptoms, risk factors, and management options.
• Encouragement for patients, caregivers, clinicians, and policymakers to engage in TD-related education and advocacy during the designated week.
• May influence future funding or policy discussions by highlighting TD as a public health awareness issue, though no funding or regulatory changes are authorized by this resolution.

Context

• Tardive dyskinesia is a motor disorder commonly associated with long-term antipsychotic use; awareness initiatives can support earlier recognition and informed discussions between patients and healthcare providers.

If you’d like, I can add a short section comparing this resolution to other awareness-week designations or provide a brief primer on tardive dyskinesia for readers new to the topic.